Consultancy Services
Independent strategic advisory support across quality, compliance and manufacturing. Engagements are focused on clarifying risk exposure, strengthening CMC positioning and enabling confident regulatory and manufacturing progression.
Strategic CMC & Manufacturing Oversight
- Independent review of development and manufacturing strategy
- Identification of regulatory and technical risk exposure
- Manufacturing readiness assessment and progression planning
- Tech transfer oversight and risk mitigation support
Quality & Compliance Leadership
- GMP system assessment and strengthening
- Inspection readiness and remediation strategy
- Validation and qualification oversight
- Quality risk management framework alignment
Advanced Therapies & Complex Biologics
- Support across monoclonal antibodies, recombinant proteins and vaccines
- Viral vector and ATMP programme oversight
- Cross-functional alignment during development inflection points
- Regulatory authority interaction preparation
Representative Challenges I Support
- Programmes approaching regulatory submission with unresolved CMC strategy questions
- Manufacturing environments requiring rapid strengthening of GMP systems prior to inspection
- Advanced therapy programmes navigating scale-up complexity and comparability risk
- Leadership teams seeking independent oversight during critical development inflection points
- Organisations managing remediation following audit findings or regulatory observations
- Biotech companies preparing for investment, partnership or acquisition scrutiny
Engagement Model
Engagements may be advisory, project-based or interim in nature. Support is tailored to programme phase and organisational structure, with flexibility to provide independent challenge, leadership reinforcement or focused remediation guidance.
If you are navigating a complex development or manufacturing milestone, independent strategic input can reduce risk and strengthen confidence in next steps.